文献速递医学教育与科研方法临床试验与 GCP

副主要研究者与HEAL-COVID试验:对受训者有益,对试验也有益

Associate Principal Investigators and the HEAL-COVID trial: good for trainees, good for trials.
PubMed 文献 · Trials · 2024-01-27

该研究描述英国国家卫生与护理研究所(NIHR)副主要研究者(API)计划在HEAL-COVID适应性平台试验中的实施经验,通过定性方法探讨该计划对API职业发展的影响,并通过多因素分析量化API对患者招募的影响。结果显示,有至少一名API的中心招募患者数超过无API中心的3.5倍(中位数4 vs 14.5,p < 0.05),且不受医院类型或住院床位数量等因素影响。

要点

  • 有至少一名API的中心招募患者数超过无API中心的3.5倍(中位数4 vs 14.5,p < 0.05)。
  • 14名完成NIHR调查的API均报告完成良好临床实践(GCP)培训、参与本地试验推广活动、患者招募及获得主要研究者支持。
  • 注册试验至API计划不仅培训未来临床研究者,还可能增加招募患者数量,提高试验效率并改善患者可及性。

核心结论

  • 注册试验至API计划不仅培训未来临床研究者,还可能增加招募患者数量,提高试验效率并改善患者可及性。
  • 本研究补充了日益增多的文献,表明NIHR的API计划在提供临床研究者研究培训、建设未来临床研究者队伍方面有效实现其目标。
  • HEAL-COVID试验数据显示,有API的中心与更高的招募量相关。

研究设计与样本

  • HEAL-COVID适应性平台试验为注册至API计划的紧急公共卫生研究,开放后18个月内招募近1200名患者,活跃中心超过100个。
  • 通过API申请表数据描述其专业背景,通过月度会议记录描述HEAL-COVID API网络,通过NIHR 6个月退出调查和最终网络会议反思实践练习回顾API经验。
  • 通过多因素分析对有API和无API中心的患者招募数据进行对比。

主要发现

  • 42名API注册至HEAL-COVID试验,背景在性别、国家、专业、级别和专科方面具有多样性。
  • 共举行11次月度网络会议,双重目标为促进试验活动和提供教育内容。
  • 14名API完成NIHR调查,均报告完成良好临床实践(GCP)、参与本地试验推广活动、患者招募及获得各自主要研究者支持。
  • 有至少一名API的中心招募患者数超过无API中心的3.5倍(中位数4 vs 14.5,p < 0.05),且不受医院类型或住院床位数量等因素影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The NIHR's Associate Principal Investigator (API) Scheme in the United Kingdom was expanded nationally in 2020 with the aim of training clinicians to become Principal Investigators for clinical research in the future. The HEAL-COVID adaptive platform trial is an urgent public health study registered with the API Scheme. Within eighteen months of opening, the trial had recruited almost 1200 patients with over 100 active sites. Here we describe our experiences of APIs working on the trial with two broad objectives. Firstly, we aim to explore through qualitative methods the impact that the scheme has had on the APIs' professional development. Secondly, we aim to quantify the impact that the APIs have had on the recruitment of patients into the trial. METHODS: The professional backgrounds of the APIs are described from data from their application forms to the scheme. The HEAL-COVID API Network is described from records of the monthly meetings. The APIs' experiences are reviewed from data from the NIHR exit surveys at 6 months and from a reflective practice exercise at the final network meeting. Data of patient recruitment to HEAL-COVID was analysed for centres with and without APIs via a multivariate analysis. RESULTS: Forty-two APIs were registered with the HEAL-COVID trial with a diversity of backgrounds in terms of gender, country, profession, grade and specialty. Eleven monthly network meetings took place with the dual objectives of facilitating trial activity and providing educational content. Fourteen APIs completed the NIHR survey with all reporting Good Clinical Practice completion, local promotional activity of the trial, patient recruitment and support from their respective PI. Sites with at least one API recruited over 3.5 times more patients than sites without an API (medians 4 vs 14.5, p < 0.05), independent of factors including type of hospital or number of inpatient beds. DISCUSSION: This study adds to the growing literature that the NIHR's API Scheme is effective in meeting its objectives in providing research training to clinicians, thus building a workforce of future clinical researchers. Moreover, data from the HEAL-COVID trial shows that sites with an API are associated with higher recruitment. Overall, registering a trial with the API Scheme not only trains future clinical researchers, but it is also likely to increase the number of patients recruited (amongst other benefits), increasing the efficiency of trials and improving access for patients.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Newman J, Wild P, Summers C, et al. Associate Principal Investigators and the HEAL-COVID trial: good for trainees, good for trials. Trials. 2024. PMID: 38281039. doi:10.1186/s13063-024-07936-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。